The Peptide Observer

Peptide research, explained for people who are not scientists.

Quick answer

What is Cortexin?

Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk. No qualified clinical reviewer. How this site works

Cortexin is a peptide, grouped on this site under Short peptide bioregulators, and the 12 research records kept here are 4 from studies in rats or mice, 2 from trials in people and 6 that do not state what kind of study it is.

The literature search returned 181 records. This site keeps 12 of them, which is 6.6 per cent of what came back.

What it is

This site puts it in the Short peptide bioregulators group.

A cortical polypeptide preparation rather than a single molecule; the retrieved 2015 review discusses neuroprotective targets and the 2021 rat study compares it with other neurotrophic preparations, with no single receptor named.[1, 2]

Stated in the titles of the cited 2015 Zhurnal Nevrologii i Psikhiatrii review and 2021 PLoS One paper.

What kind of records

No public chemistry record was found under this name, so the entry describes a preparation, a protein or a mixture rather than one defined molecule.

That sentence is produced by counting, not by reading. What was counted: PubChem returned no compound record for this name, so the subject is a preparation, protein or mixture rather than a defined small molecule; identity fields are unsourced.

What this does not settle

Where this comes from

The records cited above, in full.

  1. [Cortexin. Molecular mechanisms and targets of neuroprotective activity]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2015). pmid:26356623
  2. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PloS one (2021). pmid:34260655